PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Oct-2025 Ono Announces ONO-4578 (EP4 antagonist) in Combination with Opdivo and Chemotherapy Met the Primary Endpoint in a Phase 2 Clinical Trial in Patients with Certain Gastric Cancer Businesswire
09-Oct-2025 Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors Businesswire
09-Oct-2025 Renesas Expands Industrial Sensing Portfolio with 3 Magnet-Free Inductive Position Sensor ICs and Innovative, Web-Based Solution Design Tool Businesswire
09-Oct-2025 Mission Bio Appoints Dr. Zivjena Vucetic as Chief Medical Officer to Lead Clinical Adoption and Biopharma Partnerships Businesswire
09-Oct-2025 GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program Businesswire
09-Oct-2025 Nu-Tek BioSciences Highlights Animal-Free Ingredient Advantages at SIMB RAFT 2025 Businesswire
09-Oct-2025 New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therapy Candidate for Chronic Pain Businesswire
09-Oct-2025 CareChoice Recognized With "Outstanding Growth Award" by HHAeXchange at 2025 PA Customer Summit ACCESS Newswire
09-Oct-2025 Ascendis Submits Marketing Authorisation Application to the European Medicines Agency for TransCon CNP for Treatment of Children with Achondroplasia ASCENDIS PHARMA
09-Oct-2025 Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for High Efficiency Gene Insertion in Dividing and Non-Dividing Cells Using ARCUS Nucleases Businesswire
09-Oct-2025 Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025 Businesswire
09-Oct-2025 PharmNovo secures CTA approval in Spain initiating Phase IIa proof-of-concept trial of PN6047 for neuropathic pain PharmNovo
09-Oct-2025 Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025 Businesswire
09-Oct-2025 FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of CSCC Regeneron Pharmaceuticals, Inc.
09-Oct-2025 Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE® (Vamorolone) in Russia Santhera
09-Oct-2025 Tensive publishes positive long-term clinical follow-up data in Breast Cancer on REGENERA™ / SOFTAG™ breast implant Tensive
09-Oct-2025 Novakand Pharma provides an update on the ongoing reverse take over process Novakand Pharma
09-Oct-2025 Resolution Therapeutics announces upcoming presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2025 Resolution Therapeutics
09-Oct-2025 Orexa Announces Positive Interim Data for its Phase 2 Trial in the Prevention of Post-Operative Ileus Orexa
09-Oct-2025 Glen Clova Scientific Announces Clinical Advisory Board for its Immuno-Dermatology Pipeline Glen Clova Scientific